These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10950027)

  • 1. Hemodynamic assessment of pharmacological response in the treatment of portal hypertension: a need to know.
    Grace ND
    Am J Gastroenterol; 2000 Aug; 95(8):1862-4. PubMed ID: 10950027
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding.
    Lebrec D
    Hepatogastroenterology; 1990 Dec; 37(6):556-60. PubMed ID: 1981204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U; Bellis L; Puoti C; Burroughs AK
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug therapy of portal hypertension due to cirrhosis.
    Benhamou JP; Lebrec D
    Semin Liver Dis; 1982 Aug; 2(3):227-32. PubMed ID: 6129706
    [No Abstract]   [Full Text] [Related]  

  • 5. Wedged hepatic vein pressure (WHVP): ready for prime time.
    Boyer TD
    Hepatology; 2006 Mar; 43(3):405-6. PubMed ID: 16496346
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of pharmacological agents on portal hypertension: a haemodynamic appraisal.
    Bosch J
    Clin Gastroenterol; 1985 Jan; 14(1):169-84. PubMed ID: 2859134
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G
    J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers to prevent esophageal varices--an unfulfilled promise.
    Mukherjee S; Sorrell MF
    N Engl J Med; 2005 Nov; 353(21):2288-90. PubMed ID: 16306528
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-blockers to prevent gastroesophageal varices in cirrhosis.
    Post AB
    N Engl J Med; 2006 Mar; 354(12):1318-20; author reply 1318-20. PubMed ID: 16554538
    [No Abstract]   [Full Text] [Related]  

  • 11. [New trends in the treatment of hemodynamic disorders in liver cirrhosis].
    Vorob'ev LP; Maev IV
    Klin Med (Mosk); 1991 Sep; 69(9):11-4. PubMed ID: 1687073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic venous pressure gradient: to measure or not to measure, that is the question.
    Sanyal AJ
    Hepatology; 2000 Nov; 32(5):1175-6. PubMed ID: 11050073
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of pituitrin in hemorrhage from the esophageal veins and during surgery of patients with portal hypertension].
    Tsatsanidi KN; Novik MG; Shertsinger AG
    Vestn Khir Im I I Grek; 1970 May; 104(5):29-33. PubMed ID: 5449357
    [No Abstract]   [Full Text] [Related]  

  • 14. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J
    J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.
    Gatta A; Sacerdoti D; Merkel C; Milani L; Battaglia G; Zuin R
    Am Heart J; 1984 Oct; 108(4 Pt 2):1167-72. PubMed ID: 6148880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological treatment of the portal hypertension].
    Castañeda Romero B
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():64-5. PubMed ID: 17471863
    [No Abstract]   [Full Text] [Related]  

  • 18. [Primary prevention of variceal bleeding in cirrhosis].
    Schepke M
    Dtsch Med Wochenschr; 2006 Jun; 131(22):1269-72. PubMed ID: 16755423
    [No Abstract]   [Full Text] [Related]  

  • 19. Empiric beta-blockers for the prophylaxis of variceal hemorrhage: cost effective or clinically applicable?
    Rubenstein JH; Inadomi JM
    Hepatology; 2003 Feb; 37(2):249-52. PubMed ID: 12540773
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental studies on problems of the surgical treatment of portal hypertension].
    Kreuzer W
    Wien Klin Wochenschr Suppl; 1973; 13():3-17. PubMed ID: 4515730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.